A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2011
12/15/2011	WO2011156780A2 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/15/2011	WO2011156775A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/15/2011	WO2011156710A2 Combination therapy with lisdexamphetamine and extended release guanfacine
12/15/2011	WO2011156646A2 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/15/2011	WO2011156640A2 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
12/15/2011	WO2011156518A2 Estrogen receptor modulators and uses thereof
12/15/2011	WO2011156479A2 Trkb agonists and methods of use
12/15/2011	WO2011156331A2 Human neural progenitor derived dopaminergic progenitors and neurons
12/15/2011	WO2011156329A2 Methods of treating pain and morphine tolerance via modulation of hedgehog signalling pathway
12/15/2011	WO2011156003A2 Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
12/15/2011	WO2011155797A2 Hemioxalate salt of crystalline o-desmethylvenlafaxine, preparation method thereof, and pharmaceutical composition thereof
12/15/2011	WO2011154887A1 Mellitin for the use thereof in the treatment of parkinson's disease
12/15/2011	WO2011154725A2 Compositions
12/15/2011	WO2011154431A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011	WO2011154374A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011	WO2011154327A1 Nitrogen containing heteroaryl compounds
12/15/2011	WO2011153939A1 Agomelatine intermediates and preparation method thereof
12/15/2011	WO2011153929A1 New use of icariin and epimedium flavonoids containing icariin
12/15/2011	WO2011153819A1 Pharmaceutical composition for treating drug addiction
12/15/2011	WO2011153678A1 Composition containing iridoids and uses thereof
12/15/2011	WO2011153583A1 Nociceptin mimetics
12/15/2011	WO2011123719A3 Use of faah inhibitors for treating abdominal, visceral and pelvic pain
12/15/2011	WO2011121607A3 Rasagiline and its pharmaceutically acceptable salts
12/15/2011	WO2011106691A3 Curcumin derivatives
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306673 Crystalline forms of (1rs,2rs,6rs)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
12/15/2011	US20110306672 Ceramide-analogous metabolites
12/15/2011	US20110306669 Rapid onset and short term modafinil compositions and methods of use thereof
12/15/2011	US20110306664 Medical dietary composition for treating neurodegenerative diseases
12/15/2011	US20110306654 Methods for identifying analgesic agents
12/15/2011	US20110306652 Compositions and their uses directed to huntingtin
12/15/2011	US20110306648 Apoptosis inhibitor
12/15/2011	US20110306642 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
12/15/2011	US20110306638 Benzisoxazole piperidinyl derivatives, pharmaceutical compositions comprising the derivatives and their use
12/15/2011	US20110306637 Modulators of atp-binding cassette transporters
12/15/2011	US20110306633 Selective m4 receptor antagonist and its medical use
12/15/2011	US20110306631 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306628 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/15/2011	US20110306627 Morphinan Compounds
12/15/2011	US20110306626 Imidazolinone derivatives as cgrp receptor antagonists
12/15/2011	US20110306625 Compounds and compositions as protein kinase inhibitors
12/15/2011	US20110306621 Acylguanidine derivatives
12/15/2011	US20110306607 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/15/2011	US20110306604 3- and 6-quinolines with n-attached heterocyclic cgrp receptor antagonists
12/15/2011	US20110306603 Large substituent, non-phenolic opioids and methods of use thereof
12/15/2011	US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011	US20110306601 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression
12/15/2011	US20110306600 Novel therapeutic compounds
12/15/2011	US20110306596 Benzazepine inhibitors of gamma-secretase
12/15/2011	US20110306595 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/15/2011	US20110306593 Gamma secretase modulators
12/15/2011	US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	US20110306591 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
12/15/2011	US20110306590 Aryl- and heteroaryl- nitrogen-heterocyclic compounds as pde10 inhibitors
12/15/2011	US20110306589 Nitrogen containing heteroaryl compounds
12/15/2011	US20110306588 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
12/15/2011	US20110306587 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
12/15/2011	US20110306586 NMDA Receptor Modulators and Uses Thereof
12/15/2011	US20110306584 Porphyrin Catalysts and Methods of Use Thereof
12/15/2011	US20110306582 Androgen pharmaceutical composition and method for treating depression
12/15/2011	US20110306579 Methods of neuroprotection using neuroprotective steroids and a vitamin d
12/15/2011	US20110306559 Methods and compositions for treating neuropathic pain
12/15/2011	US20110306558 Prosaposin as a neurotrophic factor
12/15/2011	US20110306557 Neural regeneration peptides and methods for their use in treatment of brain damage
12/15/2011	US20110306556 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
12/15/2011	US20110306550 Apoe analogs and methods for their use
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305756 Coated solid preparation
12/15/2011	US20110305755 Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
12/15/2011	US20110305751 Glutathione-based drug delivery system
12/15/2011	US20110305731 Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarries
12/15/2011	US20110305729 Scriptaid Isosteres and Their Use in Therapy
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305715 Antibodies to 3-hydroxycotinine and methods of use thereof
12/15/2011	US20110305711 Cgrp antibodies
12/15/2011	US20110305706 Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
12/15/2011	US20110305701 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305677 Human embryonic stem cell cultures, and compositions and methods for growing same
12/15/2011	US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011	US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305632 Process for the preparation of asymmetrical bis(thiosemicarbazones)
12/15/2011	US20110305631 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
12/15/2011	US20110303573 Omega 3 fatty acid formulations
12/15/2011	DE102010023828A1 Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält A pharmaceutical preparation containing entacapone, levodopa and carbidopa
12/15/2011	CA2802127A1 New use of icariin and epimedium flavonoids containing icariin
12/15/2011	CA2802125A1 Composition containing iridoids and uses thereof
12/15/2011	CA2802102A1 Cgrp antibodies
12/15/2011	CA2802093A1 Combination therapy with lisdexamphetamine and extended release guanfacine
12/15/2011	CA2802005A1 Compositions comprising buprenorphine
12/15/2011	CA2801822A1 Agomelatine intermediates and preparation method thereof
12/15/2011	CA2801415A1 Trkb agonists and methods of use
12/15/2011	CA2800673A1 Estrogen receptor modulators and uses thereof
12/15/2011	CA2799640A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011	CA2799635A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)

1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 1833